HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shogo Nakayama Toshihiko Ban Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakayama, S. Articles by Okamoto, Y. Search for Related Content PubMed PubMed Citation Articles by Nakayama, S. Articles by Okamoto, Y.

J Thorac Cardiovasc Surg 1994;108:583-586
© 1994 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

Fetal bovine serum is not necessary for the cryopreservation of aortic valve tissues

Kyoto, Japan

From the Department of Cardiovascular Surgery, Faculty of Medicine, Kyoto University, Kyoto, Japan.

Received for publication Nov. 9, 1993. Accepted for publication Feb. 4, 1994. Address for reprints: Shogo Nakayama, MD, Department of Cardiovascular Surgery, Osaka Red Cross Hospital, 5-53, Fudegasaki-cho, Tennoji-ku, Osaka, 543, Japan.

Abstract

The purpose of this study was to estimate the protective effects of fetal bovine serum on the cryopreservation of aortic valve tissues. Ten porcine aortic valves were divided into two groups according to the nutrient content of the medium used for sterilization and cryopreservation. Group A valves were preserved in Dulbecco's modified Eagle medium containing 10% fetal bovine serum, whereas group B valves were preserved in Dulbecco's modified Eagle medium alone. The fibroblast viability of the cryopreserved tissues was assessed autoradiographically with the use of tritiated proline at the following points: fresh control, after sterilization, and after storage for 1 week or 3 months. The proportion of viable fibroblasts decreased to a similar extent in both groups of tissues after 1 week of storage, 81.1%±2.5% in group A and 80.4%±3.3% in group B, and after 3 months of storage it decreased slightly to around 73% for both groups of tissues. No significant difference was observed between the two groups at any time. These results suggest that fibroblasts are adequately preserved even after 3 months of cryopreservation, and that the addition of fetal bovine serum to the medium does not further improve their viability. Thus, from a point of view of fibroblast viability, it is not necessary to use fetal bovine serum for the cryopreservation of aortic valve tissues. (J THORACCARDIOVASCSURG1994;108:583-6)

This article has been cited by other articles:

				A. Ohkado, M. Hachida, H. Furukawa, H. Lu, N. Hanayama, H. Hoshi, and H. Koyanagi Should the Aortic Valve Homograft Be Recryopreserved? Ann. Thorac. Surg., April 1, 1998; 65(4): 1083 - 1086. [Abstract] [Full Text] [PDF]

				Y. C. Song, L. Y. Yao, J. M. Kneebone, and F. M. Lupinetti EFFECT OF CRYOPRESERVATION AND HISTOCOMPATIBILITY ON TYPE I PROCOLLAGEN GENE EXPRESSION IN AORTIC VALVE GRAFTS J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 421 - 427. [Abstract] [Full Text]